Gottlieb goes to Weisscom Partners

Cohn & Wolfe healthcare head Jennifer Gottlieb has jumped ship to bicoastal boutique Weisscom Partners.

Gottlieb, who was EVP and managing director of the PR firm's New York healthcare practice, becomes managing director and head of East Coast operations at Weisscom, which handles Genentech's oncology franchise as well as several GlaxoSmith-Kline accounts.

After nine years at Cohn & Wolfe, Gottlieb said, “It was going to take a very unique and different opportunity to get me to leave. Weiscomm is a growing operation, and it's something I haven't done.”

With offices in New York and San Francisco, Weisscom, which handles product and corporate communications and investor relations, boasts a staff of 30. 

Weisscom principals Jim Weiss and Dianne Weisler worked with Gottlieb in her days at Makovsky in the 1990s, when Weisler was a colleague and Weiss was a client with RPR, later absorbed into Aventis.

You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.